Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center,Open-label Real-world Study to Evaluate the Efficacy and Pharmaco-economics of Lacosamide as First Add-on Therapy for Adults and Children With Focal Onset Seizures

NCT04737837 is registered in ClinicalTrials.gov with Jiangxi Qingfeng Pharmaceutical Co. Ltd. as lead sponsor.

NCT NCT04737837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04737837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center,Open-label Real-world Study to Evaluate the Efficacy and Pharmaco-economics of Lacosamide as First Add-on Therapy for Adults and Children With Focal Onset Seizures
Lead sponsor
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2021
Completion date
February 28, 2022
Enrollment
200 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, focal-onset seizure